Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
12. November 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 9144
Articles 1 - 20 / 182868
Biomarker-led advances in renal cell carcinoma diagnosis, progression monitoring and therapeutic decision-making.
Expert Rev Mol Diagn
Lasorsa F, Pandolfo SD, Claps F, Lambertini L, Milella M, Rutigliano M, Ferro M, Ditonno P, Lucarelli G.
PMID: 43015135 [PubMed - as supplied by publisher]
Toxicity and patient-reported quality of life through 12 months following pelvis-inclusive once-weekly stereotactic body radiotherapy versus conventional IMRT for high-risk prostate cancer: updated results of the SRAM randomized phase II trial.
Radiother Oncol
Poon DM, Wong KC, Lam DC, Chan CF, Chen AC, Johnson D, Lam BH, Lee MM, Chan LL, Chu CC, Ng CF, Mo FK, Chan AT, Mok T.
PMID: 43014569 [PubMed - as supplied by publisher]
Q&A with Dr. Philip Awadalla.
Cell Genom
Awadalla P.
PMID: 43014278 [PubMed - indexed for MEDLINE]
Modernization of a Historical Prostate Cancer Registry using Artificial Intelligence: A Tale of Two Large Language Models.
J Urol
Wang MK, Galatowitsch P, Diaz-Cabo J, O'Byrne J, Li EV, Linder BJ, Kwon E, Leibovich BC, Sharma V, Gettman MT, Tollefson MK, Karnes RJ, Boorjian SA, Khanna A.
PMID: 43013751 [PubMed - as supplied by publisher]
Metabolomic profiling of renal cell carcinoma to identify prognostic markers of metastasis.
PLoS One
Williams M, Chakraborty A, Main B, Li L, Chan YC, Wang X, Verbeeck N, Spiers L, Routten O, Chin T, Bejar K, Troyer D.
PMID: 43013589 [PubMed - indexed for MEDLINE]
Circulating Tumor DNA in Oligoprogressive Prostate Cancer Treated With Stereotactic Radiotherapy: A Prespecified Secondary Analysis of a Nonrandomized Clinical Trial.
JAMA Netw Open
Reid A, Tran A, Thakali S, Wetterskog D, Orlando F, Wingate A, Patel P, Cole A, Frew J, Mullassery V, van As N, Suh YE, Demichelis F, Tree A, Attard G.
PMID: 43013307 [PubMed - indexed for MEDLINE]
Long-term outcomes of radical prostatectomy versus radiation therapy for high- and very high-risk localized prostate cancer: an IPTW analysis from a multicenter Asian database.
Int Urol Nephrol
Chu CW, Liu HY, Chang YL, Liu YY, Wang HJ, Chen YT, Cheng YT, Kang CH, Tee WQ, Yu TY, Lee IW, Luo HL.
PMID: 43013243 [PubMed - as supplied by publisher]
Real-world performance of pelvic MRI and abdominopelvic CT for nodal staging in higher-risk prostate cancer and the incremental clinical value of CT.
World J Urol
Merani U, Arcuri O, Calleris G, Sasia A, Dematteis A, Venturi A, Marquis A, Gatti M, Grimaldi S, Rovera G, Morbelli S, Oderda M, Gontero P, Marra G.
PMID: 43013110 [PubMed - indexed for MEDLINE]
Machine Learning Applications in Prostate Cancer Genomics: From Mutation Signatures to Clinical Prediction Models.
Res Rep Urol
Coman RA, Elec FI, Iancu DM, Guven S, Tokas T, Juliebø-Jones P, Tzelves L, Somani BK.
PMID: 43011873 [PubMed]
Extracellular vesicles as integrative hubs of drug resistance in bladder cancer.
Cancer Drug Resist
Huang CS, Yu CP, Yu DS, Wu YS, Jiang SS, Zhao R, Lee DF, Ho JY.
PMID: 43011771 [PubMed]
Bladder cancer immune microenvironment: immune-cell distribution, disease associations, treatment remodeling, and baseline immune features associated with treatment response and prognosis.
Front Oncol
Qin S, Yu X, Zuo S, He X, Liu J.
PMID: 43011329 [PubMed]
C-reactive protein-albumin-lymphocyte index and survival outcomes in renal cell carcinoma: a systematic review and meta-analysis.
Front Oncol
Wei Y, Mai L, Zhang X, Zhang Y, Lin Y.
PMID: 43011006 [PubMed]
Development and validation of a machine learning-based model for predicting survival in patients with bladder neuroendocrine carcinoma: a large retrospective study.
Front Oncol
Qi S, Dong W, Shi Z, Sun Y, Zhang D, Liu C, Li H, Hu L.
PMID: 43010898 [PubMed]
A DNA Nanoplatform with Rolling Circle-DNAzyme Feedback Programming for Autonomous Exponential Amplification Enables Multiplexed Orthogonal miRNA Profiling toward Precise Diagnosis of Bladder Cancer.
Anal Chem
Yang M, Chen H, Mao H, Ye X, Fan H, Sheng Y, Zhang Y.
PMID: 43010419 [PubMed - indexed for MEDLINE]
Does imaging-based clinical staging improve the predictive performance of the CAPRA score?
BMC Urol
Iplikci A, Canpolat HE, Gunduz N, Cakici MC, Yildirim A.
PMID: 43009921 [PubMed - indexed for MEDLINE]
Geometry based gene-expression signatures detect cancer treatment responders in clinical trials.
BMC Cancer
Chachólski W, Ramanujam R.
PMID: 43009859 [PubMed - indexed for MEDLINE]
Tumor-derived microRNAs as early predictive biomarkers for toxicity induced by immunotherapy in urothelial cancer.
J Cancer Res Clin Oncol
Gaibar M, Romero-Lorca A, Rodríguez-Piñas JM, Rubio M, Pérez-Ortiz JM, Malón D, Hernando S, Alemany I, Camacho FI, Cavanagh M, Gómez P, Marrupe D, Martín AM, Khedaoui R, Fernández-Santander A, Novillo A.
PMID: 43009659 [PubMed - indexed for MEDLINE]
Prospective and genetic analyses implicate lower immunosurveillance in the aetiology of prostate cancer.
Nat Commun
Parsaeian M, Chan WC, Atkins JR, Papier K, Breeur M, Desai TA, Huang Z, Ogamba CF, Conti DV, Bogumil D, Shen J, Sim MJW, Tsilidis KK, Yarmolinsky J, Rinaldi S, Kaaks R, Katzke V, Schulze MB, Schiborn C, Caini S, Milani L, Zamora-Ros R, Guevara M, Sánchez MJ, Chirlaque MD, Amiano P, PRACTICAL Consortium, Elliott T, Mills IG, Riboli E, Le Marchand L, Haiman C, Key TJ, Smith-Byrne K, Travis RC.
PMID: 43009480 [PubMed - indexed for MEDLINE]
Spatial transcriptomics tumor microenvironment determinants of tyrosine kinase inhibitor response in renal cell carcinoma: results from a phase 2 clinical trial.
Signal Transduct Target Ther
Hasanov E, Ali MIH, Deshmukh S, Ovando-Ricardez JA, Lam T, Hoang A, Liu XD, Wang X, Peterson CB, Xiao L, Matin SF, Sircar K, Tannir NM, Hasanov M, Jonasch E.
PMID: 43009462 [PubMed - indexed for MEDLINE]
Nanoparticle delivery of phytochemicals and dietary factors for epigenetic modulation in prostate cancer.
Urol Oncol
Malik A, Ravinuthala RP, Jha AK.
PMID: 43009428 [PubMed - as supplied by publisher]
Articles 1 - 20 / 182868
Page 1 of 9144
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy